Skip to content

Clinical trials

alpha 1-Antitrypsin Deficiency trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: alpha 1-Antitrypsin Deficiency Country / region: Canada Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20091
20141
20165
20171
20182
20202
20211
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated3
Recruiting2
Unknown status1
Active, not recruiting1
Withdrawn1
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Arbor Research Collaborative for Health2
Baxalta now part of Shire2
CSL Behring2
Grifols Therapeutics LLC2
Takeda2
Vertex Pharmaceuticals Incorporated2
Arrowhead Pharmaceuticals1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1
Gerard Turino1
Kamada, Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
alpha 1-Antitrypsin Deficiency19
Emphysema6
Pulmonary Disease, Chronic Obstructive4
Alagille Syndrome2
Cholestasis2
Pulmonary Emphysema2
Asthma1
Biliary Atresia1
Bronchiectasis1
Bronchopulmonary Dysplasia1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.